Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Join
FREE
12
Mins
21 Nov 2025
Targeted Therapy for Interstitial Lung Disease and the Role of Nerandomilast
This article reviews data on the efficacy and safety of nerandomilast in IPF and PPF, including the latest updates presented at ATS 2025…
21 Nov 2025
Ivermectin/Permethrin Dual Treatment Significantly Improves Outcomes in Paediatric Persistent Scabies
A study shows adding oral ivermectin to permethrin improves cure rates and speeds symptom relief in children with persistent scabies, with regular follow-up over several months.
November 2025
EMJ Respiratory 13 [Supplement 2] 2025
Our latest symposium review summarises several Boehringer Ingelheim presentations and posters on the role of nerandomilast, an oral…
20 Nov 2025
Paternal Valproate Use Linked to Neurodevelopmental Disorders
New evidence suggests paternal valproate use may increase child neurodevelopmental risk, prompting new clinical guidance considerations.
20 Nov 2025
Scientists Identify ALYREF Biomarker That Could Transform Bladder Cancer Treatment
Researchers identify ALYREF as a dual-role biomarker in bladder cancer, linked to aggressive disease yet improved immunotherapy response.
20 Nov 2025
Respiratory and Cardiovascular Diseases: A Genetic Link ?
Although genetic analysis shows little direct link between chronic respiratory and cardiovascular diseases, shared factors like smoking and inflammation drive risk in both conditions.
Novartis plans manufacturing hub in North Carolina
Novartis is the latest pharma company to announce a new plant in the US, selecting North Carolina’s ‘Research Triangle’ district as its home.
20 Nov 2025
Groundbreaking Dataset to Advance Blood Cancer Diagnosis
New bone marrow image dataset powers AI to spot dysplastic cells and improve diagnosis of blood cancers.
20 Nov 2025
Yoga and Walking Improve Blood Glucose Control in Type 2 Diabetes
A pilot study shows that yoga and walking for type 2 diabetes significantly improve blood glucose outcomes, especially when combined.
20 Nov 2025
Transepidermal Water Loss Monitoring Reduces Allergy Risk
Transepidermal water loss monitoring lowered anaphylaxis rates and reaction severity during peanut oral food challenges, offering a potential tool to improve diagnostic safety.
←
1
2
3
4
5
6
7
8
9
…
1,299
1,300
1,301
→
We’ve noticed you’re accessing
from
North/South America.
View
View